Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus

  • Shirong Qiang
  • , Yusuke Nakatsu
  • , Yasuyuki Seno
  • , Midori Fujishiro
  • , Hideyuki Sakoda
  • , Akifumi Kushiyama
  • , Keiichi Mori
  • , Yasuka Matsunaga
  • , Takeshi Yamamotoya
  • , Hideaki Kamata
  • , Tomoichiro Asano

Research output: Contribution to journal › Article › peer-review

96 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science